m-Nisoldipine

CAS No. 113578-26-0

m-Nisoldipine( 3-methyl 5-(2-methylpropyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate )

Catalog No. M28438 CAS No. 113578-26-0

m-Nisoldipine is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 170 Get Quote
5MG 262 Get Quote
10MG 392 Get Quote
25MG 650 Get Quote
50MG 888 Get Quote
100MG 1242 Get Quote
500MG 2484 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    m-Nisoldipine
  • Note
    Research use only, not for human use.
  • Brief Description
    m-Nisoldipine is a chemical compound.
  • Description
    m-Nisoldipine is a chemical compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-methyl 5-(2-methylpropyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    113578-26-0
  • Formula Weight
    388.42
  • Molecular Formula
    C20H24N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCC(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Neuropeptide W-23(hu...

    Neuropeptide W-23(human) is an endogenous ligand for NPBW1 and NPBW2.

  • HLM006474

    HLM006474 is a pan inhibitor of E2F. This inhibits E2F4 DNA-binding (IC50: 29.8 μM in A375 cells).HLM006474 causes the viability of both SCLC and NSCLC lines (IC50 ranging from 15 to 75 μM). HLM006474 displays little activities against E2F4 DNA-binding in A375 cells at 10 and 20 μM, apparently inhibits E2F4 DNA-binding at 40 μM, and increasingly suppresses the effect at 60 and 80 μM concentrations.

  • Ethionine

    Ethionine is an antimetabolite and methionine antagonist. It also produces liver neoplasms.